Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cholestasis Reversal: Efficacy of IV Fish Oil

NCT00910104 is registered in ClinicalTrials.gov with Mark Puder as lead sponsor.

NCT NCT00910104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00910104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cholestasis Reversal: Efficacy of IV Fish Oil
Lead sponsor
Mark Puder
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2006
Completion date
January 23, 2019
Enrollment
91 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal disease, parenteral nutrition associated liver disease, short bowel syndrome